Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

From Cystic Fibrosis to COVID-19: A Medical Solution Like No Other

(Image via Dymedso Inc.) Airway clearance therapy has been a cornerstone of treatments aimed at minimizing the devastating effects of airway obstruction, infection, and inflammation caused by a buildup of mucus in lung conditions … but finding a non-invasive solutio...
Stockhouse Editorial | December 8, 2020 |

EyeGate Pharma Shares Looking Up on Pivotal PRK Ocular Bandage Gel Study Data

EyeGate Pharmaceuticals shares opened nearly 85% higher today after the company reported select topline data demonstrating that it met its primary endpoint in its cornea wound repairs pivotal photorefractive keratectomy study using the firm's Ocular Bandage Gel eye drop. ...
Streetwise Reports | November 25, 2019 |

Analyst Raises Target Price of Canadian Miner Given 'Continued Momentum'

Key points management made on a recent investor tour are presented in a BMO Capital Markets report. In a Sept. 5 research note, analyst Andrew Kaip reported that BMO Capital Markets raised its target price on Pretium Resources Inc. (PVG:TSX; PVG:NYSE) to CA$24 per s...
Streetwise Reports | September 12, 2019 |

Oil & Gas Royalty MLP Benefits from 'Record Production in Q3/19'

The quarterly highlights are provided in a Raymond James report. In a Nov. 7 research note, Raymond James analyst John Freeman wrote that Kimbell Royalty Partners, LP (KRP:NYSE) "reported record production in Q3/19, making way for about an 8% sequential distribution...
Streetwise Reports | November 26, 2019 |

Texas Oilfield Services Firm 'Well Positioned for 2020'

The factors contributing to the company's status and financial expectations for this year are discussed in a Raymond James report. In a Jan. 21 research note, Raymond James analyst Praveen Narra reported that Halliburton Co. (HAL:NYSE) is "well positioned ...
Streetwise Reports | January 30, 2020 |

ION Geophysical Shares Trade 70% Higher after Reporting 53% Rise in Q1 Sales

Shares of ION Geophysical traded higher after the company reported Q1/20 financial results that included a 53% year-over-year increase in revenue. Oil and gas technology services and solutions company ION Geophysical Corp. (IO:NYSE) yesterday afternoon an...
Streetwise Reports | May 8, 2020 |

Investing in vanadium

Metal that inspired Henry Ford In 1905, Henry Ford came across a remarkable metal that helped him to single-handedly revolutionize the budding American car industry. After a car race in Florida, Ford examined the wreckage of a French race car. He realized that many of...
Luke Burgess | October 28, 2012 |

From COVID to Nicotine Treatments, this Bio Stock is One to Watch

(Image via Lexaria Bioscience Corp.) There’s no shortage of excitement over potential COVID-19 vaccines. Just looking at the response to news around these developments is evidence of that, and one Company is working on a transformative, patented tech...
Stockhouse Editorial | December 1, 2020 |

Benefactor of Interest Rate Cuts

Last week for the first time since 2008, the Federal Reserve cut interest rates. But was this rate cut needed? The Fed has been trying to force feed consumers who contribute about 70% to GDP to keep borrowing and spending. The plan has been working thus far as the economic e...
Dr. Kal Kotecha | August 7, 2019 |

The Golden Bullet for Drug Delivery

It’s the Holy Grail in the cannabis industry. Everyone is trying to innovate the best delivery system to optimize the “bioavailability” (uptake) of medical cannabis in order to offer the perfect pairing -- precise dosing with a fast on...
Marc Davis | January 8, 2020 |
1 2 3 4 5 6 7 8 9 10 ...